# OnCo record argenx (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/argenx/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "argenx" ;
  schema:name "argenx"@en ;
  schema:alternateName "argenx SE"@en, "Argenx"@en ;
  schema:description "argenx is a Belgian antibody company best known for efgartigimod in autoimmune disease; its cancer programme, the anti-CD70 antibody cusatuzumab for acute myeloid leukaemia, was returned by its partner in 2021."@en ;
  schema:url <https://onco.cc/companies/argenx/>, <https://www.argenx.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Argenx> ;
  owl:sameAs <http://www.wikidata.org/entity/Q63152908> ;
  schema:citation <https://www.argenx.com>, <https://clinicaltrials.gov/search?lead=argenx>, <https://en.wikipedia.org/wiki/Argenx> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "BE" ;
  onco:cancers <https://onco.cc/cancers/aml/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:drugs <https://onco.cc/drugs/cusatuzumab/> ;
  onco:trials <https://onco.cc/trials/nct04023526/> .